Ratings by Jefferies (Kelly Shi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2026 | ADC Therapeutics | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2026 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | Monte Rosa Therapeutics | GLUE | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2025 | Monte Rosa Therapeutics | GLUE | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2025 | Immunitybio Inc | IBRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2025 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2025 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2025 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2025 | Moonlake Immunotherapeutics | MLTX | Downgrade | Hold (Buy) |
61.99 (19.21) |
-69.01% | Details | |
| 8/25/2025 | Zai Lab | ZLAB | New Coverage | Buy (N/A) |
33.99 (18.18) |
-46.51% | Details | |
| 8/25/2025 | Viridian Therapeutic | VRDN | New Coverage | Buy (N/A) |
18.02 (16.63) |
-7.71% | Details | |
| 8/25/2025 | Immunocore Holdings | IMCR | New Coverage | Buy (N/A) |
32.67 (31.04) |
-4.99% | Details | |
| 8/19/2025 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2025 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2025 | Cabaletta Bio Inc. | CABA | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2025 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2025 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 6/16/2025 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2025 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2025 | Insmed | INSM | New Coverage | Buy (N/A) |
65.08 (95.80) |
47.2% | Details | |
| 5/8/2025 | Verastem | VSTM | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2025 | Verastem | VSTM | New Coverage | Buy (N/A) |
4.64 (4.12) |
-11.21% | Details | |
| 4/4/2025 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2025 | Opthea Ltd. | OPT | Downgrade | Underperform (Buy) |
3.41 (3.41) |
0% | Details | |
| 3/17/2025 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2025 | Silence Therapeutics | SLN | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2025 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2025 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2025 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | Instil Bio Inc | TIL | Upgrade | Buy (Hold) |
20.61 (7.50) |
-63.61% | Details | |
| 1/6/2025 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2024 | Foghorn Therapeutics | FHTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2024 | Keros Therapeutics | KROS | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2024 | Adagene Inc | ADAG | Downgrade | Hold (Buy) |
2.32 (3.94) |
69.83% | Details | |
| 11/5/2024 | Keros Therapeutics | KROS | New Coverage | Buy (N/A) |
59.95 (10.65) |
-82.24% | Details | |
| 10/31/2024 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2024 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2024 | Centessa Pharmaceuticals | CNTA | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2024 | Foghorn Therapeutics | FHTX | New Coverage | Buy (N/A) |
7.89 (5.26) |
-33.33% | Details | |
| 9/3/2024 | Silence Therapeutics | SLN | New Coverage | Buy (N/A) |
18.75 (6.93) |
-63.04% | Details | |
| 8/13/2024 | Artiva Biotherapeutics | ARTV | New Coverage | Buy (N/A) |
11.30 (9.82) |
-13.1% | Details | |
| 7/22/2024 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2024 | Syndax Pharmaceuticals | SNDX | New Coverage | Buy (N/A) |
20.32 (19.00) |
-6.5% | Details | |
| 6/10/2024 | ProKidney Corp. | PROK | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2024 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2024 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2024 | Instil Bio Inc | TIL | Downgrade | Hold (Buy) |
10.92 (7.50) |
-31.32% | Details | |
| 4/1/2024 | Cogent | COGT | New Coverage | Buy (N/A) |
6.52 (34.54) |
429.75% | Details | |
| 3/20/2024 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2024 | ADC Therapeutics | ADCT | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Incyte | INCY | New Coverage | Buy (N/A) |
60.33 (92.03) |
52.54% | Details | |
| 2/20/2024 | ArriVent BioPharma | AVBP | New Coverage | Buy (N/A) |
22.07 (31.74) |
43.82% | Details | |
| 2/12/2024 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2024 | Cabaletta Bio Inc. | CABA | New Coverage | Buy (N/A) |
20.58 (2.85) |
-86.15% | Details | |
| 1/11/2024 | Ascendis Pharma | ASND | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2024 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2023 | Ascendis Pharma | ASND | New Coverage | Buy (N/A) |
120.89 (230.83) |
90.94% | Details | |
| 11/30/2023 | Immunogen Inc. | IMGN | Downgrade | Hold (Buy) |
16.06 (31.25) |
94.58% | Details | |
| 11/15/2023 | Centessa Pharmaceuticals | CNTA | Upgrade | Buy (Hold) |
6.24 (40.02) |
541.35% | Details | |
| 11/7/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2023 | PTC Therapeutics | PTCT | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2023 | BeiGene, Ltd. | BGNE | New Coverage | Buy (N/A) |
202.72 (184.71) |
-8.88% | Details | |
| 8/11/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/21/2023 | Legend Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2023 | Immunitybio Inc | IBRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2023 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2023 | TCR2 Therapeutics | TCRR | Downgrade | Hold (Buy) |
1.60 (1.48) |
-7.5% | Details | |
| 12/21/2022 | ProKidney Corp | PROK | New Coverage | Buy (N/A) |
8.27 (1.83) |
-77.87% | Details | |
| 12/15/2022 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2022 | Instil Bio Inc | TIL | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Moonlake Immunotherapeutics | MLTX | New Coverage | Buy (N/A) |
8.50 (61.99) |
629.29% | Details | |
| 9/12/2022 | PTC Therapeutics | PTCT | New Coverage | Buy (N/A) |
53.64 (67.00) |
24.91% | Details | |
| 9/1/2022 | CTI BioPharma | CTIC | New Coverage | Buy (N/A) |
6.11 (9.09) |
48.77% | Details | |
| 8/15/2022 | Monte Rosa Therapeutics | GLUE | New Coverage | Buy (N/A) |
9.16 (18.31) |
99.89% | Details | |
| 8/15/2022 | Kymera Therapeutics | KYMR | New Coverage | Buy (N/A) |
32.51 (90.43) |
178.16% | Details | |
| 8/3/2022 | Immunitybio Inc | IBRX | New Coverage | Buy (N/A) |
3.65 (7.36) |
101.64% | Details | |
| 3/4/2022 | Adicet Bio Inc. | ACET | New Coverage | Buy (N/A) |
12.58 (8.20) |
-34.82% | Details | |
| 1/18/2022 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2022 | BioAtla Inc. | BCAB | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2021 | Immunogen Inc. | IMGN | Upgrade | Buy (Hold) |
4.75 (31.25) |
557.89% | Details | |
| 10/19/2021 | Legand Biotech Corp. | LEGN | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2021 | Humanigen | HGEN | Downgrade | Hold (Buy) |
7.97 (0.04) |
-99.5% | Details | |
| 8/3/2021 | Hutchmed (China) Ltd. | HCM | New Coverage | Buy (N/A) |
42.79 (10.28) |
-75.98% | Details | |
| 6/14/2021 | AUTL | AUTL | Upgrade | Buy (Neutral) |
6.85 (1.51) |
-77.96% | Details | |
| 4/13/2021 | Connect Biopharma Holdings Ltd | CNTB | New Coverage | Buy (N/A) |
17.00 (2.00) |
-88.24% | Details | |
| 3/8/2021 | Adagene Inc | ADAG | New Coverage | Buy (N/A) |
22.99 (2.32) |
-89.91% | Details | |
| 10/30/2020 | Aldeyra Therapeutics | ALDX | New Coverage | Buy (N/A) |
6.42 (1.96) |
-69.47% | Details | |
| 2/11/2020 | I-Mab | IMAB | New Coverage | Buy (N/A) |
11.00 (4.63) |
-57.91% | Details |
